Skip to main content
. Author manuscript; available in PMC: 2008 Jul 16.
Published in final edited form as: J Control Release. 2007 Apr 1;120(1-2):95–103. doi: 10.1016/j.jconrel.2007.03.016

Figure 3.

Figure 3

Tumor accumulation of [3H]-CpG-ODN (●), DNP-[3H]-CpG-ODN (■), and DNP2-[3H]-CpG-ODN (▲) in CT26 tumor-bearing mice. In the case of DNP- and DNP2-[3H]-CpG-ODN, mice were immunized against DNP prior to tumor development. Data at each timepoint are shown as the average percent injected dose per gram of tumor (%ID/g) ± SEM, n= 3.